Prestige Wealth Management Group’s GSK GSK Stock Holding History

Prestige Wealth Management Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.23K	Hold	80	–	–	﹤0.01%	619
2026 Q1	$4.45K	Hold	80	–	–	﹤0.01%	580
2025 Q4	$3.96K	Hold	80	–	–	﹤0.01%	636
2025 Q3	$3.49K	Hold	80	–	–	﹤0.01%	631
2025 Q2	$3.11K	Hold	80	–	–	﹤0.01%	654
2025 Q1	$3.13K	Hold	80	–	–	﹤0.01%	654
2024 Q4	$2.74K	Hold	80	–	–	﹤0.01%	721
2024 Q3	$3.3K	Hold	80	–	–	﹤0.01%	680
2024 Q2	$3.14K	Sell	80 -80	-50%	-$3.37K	﹤0.01%	636
2024 Q1	$6.92K	Hold	160	–	–	﹤0.01%	512
2023 Q4	$5.99K	Hold	160	–	–	﹤0.01%	553
2023 Q3	$5.86K	Hold	160	–	–	﹤0.01%	551
2023 Q2	$5.76K	Hold	160	–	–	﹤0.01%	561
2023 Q1	$5.75K	Hold	160	–	–	﹤0.01%	537
2022 Q4	$5.68K	Hold	160	–	–	﹤0.01%	586
2022 Q3	$5K	Hold	160	–	–	﹤0.01%	553
2022 Q2	$9K	Hold	160	–	–	﹤0.01%	455
2022 Q1	$9K	Hold	160	–	–	﹤0.01%	485
2021 Q4	$9K	Hold	160	–	–	﹤0.01%	499
2021 Q3	$8K	Hold	160	–	–	﹤0.01%	530
2021 Q2	$8K	Hold	160	–	–	﹤0.01%	525
2021 Q1	$7K	Hold	160	–	–	﹤0.01%	550
2020 Q4	$7K	Sell	160 -19	-11%	-$873	﹤0.01%	511
2020 Q3	$9K	Hold	179	–	–	﹤0.01%	455
2020 Q2	$9K	Sell	179 -4	-2%	-$205	﹤0.01%	437
2020 Q1	$9K	Sell	183 -359	-66%	-$19.1K	﹤0.01%	396
2019 Q4	$31K	Buy	542 +23	+4%	+$1.28K	0.02%	244
2019 Q3	$28K	Hold	519	–	–	0.02%	241
2019 Q2	$26K	Sell	519 -14	-3%	-$702	0.02%	241
2019 Q1	$27K	Buy	533 +70	+15%	+$3.5K	0.02%	240
2018 Q4	$22K	Buy	+463	New	+$22.8K	0.02%	287

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Prestige Wealth Management Group's GSK Position: Q2 2026 in Review

Prestige Wealth Management Group held its GSK (GSK) position steady in Q2 2026 at 80 shares worth $4.23K. The position accounts for ﹤0.01% of the portfolio, ranked #619.

Prestige Wealth Management Group first reported a position in GSK in Q4 2018 and has held it in 31 quarters since. The position peaked at $31K in Q4 2019. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Prestige Wealth Management Group held 80 shares of GSK worth $4.23K as of Q2 2026.
Prestige Wealth Management Group left its GSK share count unchanged in Q2 2026.
GSK made up ﹤0.01% of Prestige Wealth Management Group's portfolio in Q2 2026, its #619 holding.
Prestige Wealth Management Group first reported a position in GSK in Q4 2018 and has held it in 31 quarters since.
Prestige Wealth Management Group's GSK position peaked at $31K in Q4 2019.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Prestige Wealth Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.